Survey of recent literature related to the biologically active 4(3H)-quinazolinones containing fused heterocycles

Current Medicinal Chemistry

Volumn 20, Issue 6, 2013, Pages 794-814

  Demeunynck, Martine ^a   Baussanne, Isabelle ^a  

^a Université Grenoble I   (France)

Author keywords

Antitumor agents; Antiviral; Nitrogen heterocycles; Quinazoline; Quinazolinone

Indexed keywords

ANACINE; ANTINEOPLASTIC AGENT; AURANTIOMIDE A; AURANTIOMIDE B; AURANTIOMIDE C; BATRACYLIN; CAMPTOTHECIN; CIRCUMDATIN; COTTOQUINAZOLINE D; DEHYDROEVODIAMINE; DEOXYVASICINONE; EVODIAMINE; FISCALIN A; FISCALINE B; FUMIQUINAZOLINE C; FUMIQUINAZOLINE F; FUMIQUINAZOLINE G; GLYANTRYPINE; ISAINDIGOTONE; LUOTONIN; MACKINAZOLINONE 7; MD 212; QUINAZOLINE DERIVATIVE; RUTAECARPINE; SCLEROTIGENIN; SCOPOLAMINE; TRYPTANTHRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASICINONE; [1,4] OXAZINO [3,4 B] QUINAZOLINONE;

ALZHEIMER DISEASE; ANTIFUNGAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CYTOTOXICITY; DRUG ISOLATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; IC 50; LEUKEMIA P 388; MINIMUM INHIBITORY CONCENTRATION; NEUROPROTECTION; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; VASODILATATION;

EID: 84877951432     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320060006     Document Type: Review

References (139)

1. Arora, R.; Kapoor, A.; Gill, N.S.; Rana, A.C., Quinazolinone: An overview. Int. Res. J. Pharm., 2011, 2, 21-28.
2. Sharma, P.C.; Kaur, G.; Pahwa, R.; Sharma, A.; Rajak, H., Quinazolinone analogs as potential therapeutic agents. Curr. Med. Chem., 2011, 18, 4786-4812.
3. Pendergast, W.; Johnson, J.V.; Dickerson, S.H.; Dev, I.K.; Duch, D.S.; Ferone, R.; Hall, W.R.; Humphrey, J.; Kelly, J.M.; Wilson, D.C., Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some 3-Amino-And 3-methylbenzo[f]quinazolin-1(2H)-ones. J. Med. Chem., 1993, 36, 2279-2291. (Pubitemid 23262459)
4. Hour, M.J.; Huang, L.J.; Kuo, S.C.; Xia, Y.; Bastow, K.; Nakanishi, Y.; Hamel, E.; Lee, K.H., 6-Alkylamino-And 2,3-dihydro-3'-methoxy-2-phenyl-4- quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization. J. Med. Chem., 2000, 43, 4479-4487. (Pubitemid 32046872)
5. Pendergast, W.; Dickerson, S.H.; Dev, I.K.; Ferone, R.; Duch, D.S.; Smith, G.K., Benzo[f]quinazoline inhibitors of thymidylate synthase: methyleneamino-linked aroylglutamate derivatives. J. Med. Chem., 1994, 37, 838-844. (Pubitemid 24123482)
6. De Clercq, E., New developments in anti-HIV chemotherapy. Curr. Med. Chem., 2001, 8, 1543-1572. (Pubitemid 33076802)
7. Chern, J.-W.; Tao, P.-L.; Wang, K.-C.; Gutcait, A.; Liu, S.-W.; Yen, M.-H.; Chien, S.-L.; Rong, J.-K., Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8. Synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential 1-Adrenoceptor antagonists. J. Med. Chem., 1998, 41, 3128-3141. (Pubitemid 28376520)
8. Grosso, J.A.; E., N.D.; Kohli, J.D.; Glock, D., Synthesis of 2-(alkylamino)-5,6-And -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists. J. Med. Chem., 1982, 25, 703-708. (Pubitemid 13238107)
9. Somers, F.; Ouedraogo, R.; Antoine, M.-H.; de Tullio, P.; Becker, B.; Fontaine, J.; Damas, J.; Dupont, L.; Rigo, B.; Delarge, J.; Lebrun, P.; Pirotte, B., Original 2-Alkylamino-6-halogenoquinazolin-4(3H)-ones and KATP channel activity. J. Med. Chem., 2001, 44, 2575-2585. (Pubitemid 32852147)
10. Alagarsamy, V.; Solomon, V.R.; Murugan, M., Synthesis and pharmacological investigation of novel 4-benzyl-1-substituted-4H-[1,2,4]triazolo[4,3-A] quinazolin-5-ones as new class of H1-Antihistaminic agents. Bioorg. Med. Chem., 2007, 15, 4009-4015. (Pubitemid 46678851)
11. Kumar, A.; Rajput, C.S., Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives. Eur. J. Med. Chem., 2009, 44, 83-90.
12. Alafeefy, A.M.; Kadi, A.A.; El-Azab, A.; Abdel-Hamide, S.G.; Daba, M.-H.Y., Synthesis, Analgesic and Anti-Inflammatory Evaluation of Some New 3H-Quinazolin-4-one Derivatives. Arch. Pharm. Chem. Life Sci., 2008, 341, 377-385.
13. Marzaro, G.; Guiotto, A.; Chilin, A., Quinazoline derivatives as potential anticancer agents: A patent review (2007-2010). Expert Opin. Ther. Patents, 2012, 22, 223-252.
14. Genady, A.R., Promising carboranylquinazolines for boron neutron capture therapy: Synthesis, characterization, and in vitro toxicity evaluation. Eur. J. Med. Chem., 2009, 44, 409-416
15. Patil, D.A.; Patil, P.O.; Patil, G.B.; Surana, S.J., Synthesis of 2, 3-disubstituted-Quinazolin-4-(3H)-ones. Mini Rev Med Chem, 2011, 11, 633-641.
16. Okuzumi, T.; Nakanishi, E.; Tsuji, T.; Makino, S., Efficient solid-phase synthesis of quinazoline-2,4-diones with various substituents on aromatic rings. Tetrahedron, 2003, 59, 5603-5608. (Pubitemid 36792234)
17. Connolly, D.J.; Cusak, D.; O'Sullivan, T.P.; Guiry, P.J., Synthesis of quinazolinones and quinazolines. Tetrahedron, 2005, 61, 10153-10202. (Pubitemid 41345720)
18. Mhaske, S.B.; Argade, N.P., The chemistry of recently isolated naturally occurring quinazolinone alkaloids. Tetrahedron, 2006, 62, 9787-9826. (Pubitemid 44376561)
19. Eguchi, S., Quinazoline alkaloids and related chemistry. Top. Heterocycl. Chem., 2006, 6, 113-156.
20. Vögtle, M.M.; Marzinzik, A.L., Synthetic approaches towards quinazolines, quinazolinones and quinazolinedionds on solid phase. QSAR Comb. Sci., 2004, 23, 440-459. (Pubitemid 39490406)
21. Michael, J.P., Quinoline, quinazoline and acridone alkaloids. Nat. Prod. Rep., 2008, 25, 166-187. (Pubitemid 351207542)
22. Kundu, B.; Partani, P.; Duggineni, S.; Sawant, D., Solid-phase synthesis of 2-Aminoquinazolinone derivatives with two-or three-point diversity. J. Comb. Chem., 2005, 7, 909-915. (Pubitemid 41705923)
23. Wéber, C.; Bielik, A.; Szendrei, G.; Greiner, I., Novel solid-phase synthesis of 2,6-disubstituted 4(3H)-quinazolinones for combinatorial library generation. Tetrahedron Lett., 2002, 43, 2971-2974. (Pubitemid 34286500)
24. Wéber, C.; Demeter, A.; Szendrei, G.I.; Greiner, I., Solid-phase synthesis of 2,6-And 2,7-diamino-4(3H)-quinazolinones via palladium-catalysed amination. Tetrahedron Lett., 2003, 44, 7533-7536. (Pubitemid 37102994)
25. Yang, R.-Y.; Kaplan, A., A concise and efficient solid-phase synthesis of 2-Amino-4(3H)-quinazolinones. Tetrahedron Lett., 2000, 41, 7005-7008.
26. Gopalsamy, A.; Yang, H., Combinatorial synthesis of heterocycles: solidphase synthesis of 2-Amino-4(1H)-quinazolinone derivatives. J. Comb. Chem., 2000, 2, 378-381.
27. Cledera, P.; Sanchez, J.D.; Caballero, E.; Yates, T.; Ramirez, E.G.; Avendano, C.; Ramos, M.T.; Menendez, J.C., Microwave-Assisted, solventfree synthesis of several quinazoline alkaloid frameworks. Synthesis, 2007, 3390-3398. (Pubitemid 350161669)
28. Alexandre, F.-R.; Berecibar, A.; Besson, T., Microwave-Assisted Niementowski reaction. Back to the roots. Tetrahedron Lett., 2002, 43, 3911-3913. (Pubitemid 34463061)
29. Örfi, L.; Waczek, F.; Pato, J.; Varga, I.; Hegymegi-Barakonyi, B.; Houghten, R.A.; Kéri, G., Improved, High Yield Synthesis of 3H-Quinazolin-4-ones, the Key Intermediates of Recently Developed Drugs. Curr. Med. Chem., 2004, 11, 2549-2553. (Pubitemid 39255550)
30. Siddiqui, I.R.; Singh, P.K.; Srivastava, V.; Yadav, S.; Singh, J., A novel versatile strategy for synthesis of new series of 4(3H)-quinazolinone Nnucleosides. Indian J. Chem., Section B: Organic Chemistry, 2010, 49, 1535-1541.
31. Molina, P.; Alajarin, M.; Vidal, A., New methodology for the preparation of quinazoline derivatives via tandem Aza-Wittig/heterocumulene-mediated annulation. Synthesis of 4(3H)-quinazolinones, benzimidazo[1,2-c]quinazolines, quinazolino[3,2-A]quinazolines and benzothiazolo[3,2-c]quinazolines. Tetrahedron, 1989, 45, 4263-4286.
32. Zhang, W.; Mayer, J.P.; Hall, S.E.; Weigel, J.A., A polymer-bound iminophosphorane approach for the synthesis of quinazolines. J. Comb. Chem., 2001, 3, 255-256.
33. Yu, Y.; Ostresh, J.M.; Houghten, R.A., A traceless approach for the parallel solid-phase synthesis of 2-(arylamino)quinazolinones. J. Org. Chem., 2002, 67, 5831-5834. (Pubitemid 34851626)
34. Kumar, V.; Mohan, C.; Gupta, M.; Mahajan, M.P., A catalyst-And solventfree selective approach to biologically important quinazolines and benzo[g]quinazoline. Tetrahedron, 2005, 61, 3533-3538. (Pubitemid 40357942)
35. El-Hiti, G.A.; Abel-Megeed, M.F., Synthesis of glycosides containing quinazolin-4(3H)-one ring system. Heterocycles, 2005, 65, 3007-3041.
36. Liu, J.-F., Rapid syntheses of biologically active quinazolinone natural products using microwave technology. Curr. Org. Synthesis, 2007, 4, 223-237.
37. Liu, J.-F.; Ye, P.; Sprague, K.; Sargent, K.; Yohannes, D.; Baldino, C.M.; Wilson, C.J.; Ng, A.M., Novel one-pot total syntheses of deoxyvasicinone, mackinazolinone, isaindigotone, and their derivatives promoted by microwave irradiation. Org. Lett., 2005, 7, 3363-3366. (Pubitemid 41059145)
38. Liu, J.F.; Wilson, C.J.; Ye, P.; Sprague, K.; Sargent, K.; Si, Y.; Beletsky, G.; Yohannes, D.; Ng, S.C., Privileged structure-based quinazolinone natural product-Templated libraries: identification of novel tubulin polymerization inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 686-690. (Pubitemid 43014860)
39. Cagir, A.; Eisenhauer, B.M.; Gao, R.; Thomas, S.J.; Hecht, S.M., Synthesis and topoisomerase I inhibitory properties of luotonin A analogues. Bioorg. Med. Chem., 2004, 12, 6287-6299. (Pubitemid 39440464)
40. Rao, V.A.; Agama, K.; Holbeck, S.; Pommier, Y., Batracylin (NSC 320846), a dual inhibitor of DNA topoisomerases I and II induces histone gamma-H2AX as a biomarker of DNA damage. Cancer Res., 2007, 67, 9971-9979. (Pubitemid 47621247)
41. Park, E.-J.; Suh, Y.-H.; Kim, J.-Y.; Choi, S.; Lee, C.-J., Long-lasting facilitation by dehydroevodiamine HCl of synaptic responses evoked in the CA1 region of rat hippocampal slices. NeuroRep., 2003, 14, 399-403. (Pubitemid 36337938)
42. Peng, J.-H.; Zhang, C.E.; Wei, W.; Hong, X.-P.; Pan, X.-P.; Wang, J.-Z., Dehydroevodiamine attenuates tau hyperphosporylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats. Neuropharm., 2007, 52, 1521-1527. (Pubitemid 46695738)
43. Wang, H.-H.; Chou, C.-J.; Liao, J.-F.; Chen, C.F., Dehydroevodiamine attenuates -Amyloid peptide-induced amnesia in mice. Eur. J. Pharm., 2001, 413, 221-225. (Pubitemid 32172994)
44. Decker, M., Novel inhibitors of acetyl-And butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine. Eur. J. Med. Chem., 2005, 40, 305-313. (Pubitemid 40255773)
45. Decker, M., Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. J. Med. Chem., 2006, 49, 5411-5413. (Pubitemid 44373174)
46. Chen, X.; Tikhonova, I.G.; Decker, M., Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors. Bioorg. Med. Chem., 2011, 19, 1222-1235.
47. Appenroth, D.; Decker, M.; Tränkle, C.; Mohr, K.; Lehmann, J.; Fleck, C., In vivo investigations on the cholinesterase-inhibiting effects of tricyclic quinazolinimines: Scopolamine-induced cognitive impairments in rats are attenuated at low dosage and reinforced at higher dosage. Pflugers Arch. Eur. J. Physiol., 2008, 455, 895-901. (Pubitemid 350265614)
48. Pan, L.; Tan, J.-H.; Hou, J.-Q.; Huang, S.-L.; Gu, L.-Q.; Huang, Z.-S., Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 3790-3793. (Pubitemid 351794508)
49. Zabeer, A.; Bhagat, A.; Gupta, O.P.; Singh, G.D.; Youssouf, M.S.; Dhar, K.L.; Suri, O.P.; Suri, K.A.; Satti, N.K.; Gupta, B.D.; Qazi, G.N., Synthesis and bronchodilator activity of new quinazolin derivative. Eur. J. Med. Chem., 2006, 41, 429-434.
50. Chen, Z.; Hu, G.; Li, D.; Chen, J.; Li, H.; Zhou, H.; Xie, Y., Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1). Bioorg. Med. Chem., 2009, 17, 2351-2359.
51. Astulla, A.; Zaima, K.; Matsuno, Y.; Hirasawa, Y.; Ekasari, W.; Widyawaruyanti, A.; Zaini, N.C.; Morita, H., Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities. J. Nat. Prod., 2008, 62, 470-472.
52. Pandey, S.K.; Singh, A.; Nizamuddin, Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-Triazole, [1,2,4]-Triazine and [1,2,4,5]-Tetrazine rings. Eur. J. Med. Chem., 2009, 44, 1188-1197.
53. Buttachon, S.; Chandrapatya, A.; Manoch, L.; Silva, A.; Gales, L.; Bruyere, C.; Kiss, R.; Kijjoa, A., Sartorymensin, a new indole alkaloid, and new analogues of tryptoquivaline and fiscalins produced by Neosartorya siamensis (KUFC 6349). Tetrahedron, 2012, 68, 3253-3262.
54. Zhuang, Y.; Teng, X.; Wang, Y.; Liu, P.; Li, G.; Zhu, W., New quinazolinone alkaloids within rare amino acid residue from coral-Associated fungus, Aspergillus versicolor LCJ-5-4. Org. Lett., 2011, 13, 1130-1133.
55. Fremlin, L.J.; Piggott, A.M.; Lacey, E.; Capon, R.J., Cottoquinazoline A and cotteslosins A and B, metabolites from an Australian marine-derived strain of Aspergillus versicolor. J. Nat. Prod., 2009, 72, 666-670.
56. Koyama, N.; Inoue, Y.; Sekine, M.; Hayakawa, Y.; Homma, H.; Oinmura, S.; Tomoda, H., Relative and absolute stereochemistry of quinadoline B, an inhibitor of lipid droplet synthesis in macrophages. Org. Lett., 2008, 10, 5273-5276.
57. Xin, Z.H.; Fang, Y.; Du, L.; Zhu, T.; Duan, L.; Chen, J.; Gu, Q.-Q.; Zhu, W.-M., Aurantiomides A-C, quinazoline alkaloids from the sponge-derived fungus Penicillium aurantiogriseum SP0-19. J. Nat. Prod., 2007, 70, 853-855. (Pubitemid 46953613)
58. Ames, B.D.; Haynes, S.W.; Gao, X.; Evans, B.S.; Kelleher, N.L.; Tang, Y.; Walsh, C.T., Complexity Generation in Fungal Peptidyl Alkaloid Biosynthesis: Oxidation of Fumiquinazoline A to the Heptacyclic Hemiaminal Fumiquinazoline C by the Flavoenzyme Af12070 from Aspergillus fumigatus. Biochemistry, 2011, 50, 8756-8769.
59. Ames, B.D.; Liu, X.; Walsh, C.T., Enzymatic processing of fumiquinazoline F: A tandem oxidative-Acylation strategy for the generation of multicyclic scaffolds in fungal indole alkaloid biosynthesis. Biochemistry, 2010, 49, 8564-8576.
60. Ames, B.D.; Walsh, C.T., Anthranilate-Activating modules from fungal nonribosomal peptide assembly lines. Biochemistry, 2010, 49, 3351-3365.
61. Gao, X.; Chooi, Y.-H.; Ames, B.D.; Wang, P.; Walsh, C.T.; Tang, Y., Fungal indole alkaloid biosynthesis: genetic and biochemical investigation of the tryptoquialanine pathway in Penicillium aethiopicum. J. Am. Chem. Soc., 2011, 133, 2729-2741.
62. Haynes, S.W.; Ames, B.D.; Gao, X.; Tang, Y.; Walsh, C.T., Unraveling Terminal C-Domain-Mediated Condensation in Fungal Biosynthesis of Imidazoindolone Metabolites. Biochemistry, 2011, 50, 5668-5679.
63. Wang, Y.; Kong, C.; Du, Y.; Song, H.; Zhang, D.; Qin, Y., Silver-promoted Friedel-Crafts reaction: concise total synthesis of (-)-Ardeemin, (-)-Acetylardeemin and (-)-formylardeemin. Org. Biomol. Chem., 2012, 10, 2793-2797.
64. He, B.; Song, H.; Du, Y.; Qin, Y., Total Synthesis of (-)-Ardeemin. J. Org. Chem., 2009, 74, 298-304.
65. Takiguchi, S.; Iizuka, T.; Kumakura, Y.-s.; Murasaki, K.; Ban, N.; Higuchi, K.; Kawasaki, T., Total Syntheses of (-)-Fructigenine A and (-)-5-NAcetylardeemin. J. Org. Chem., 2010, 75, 1126-1131.
66. Leca, D.; Gaggini, F.; Cassayre, J.; Loiseleur, O.; Pieniazek, S.N.; Luft, J.A.R.; Houk, K.N., Acid-Catalyzed Aza-Diels-Alder Reactions for the Total Synthesis of (±)-Lapatin B. J. Org. Chem., 2007, 72, 4284-4287. (Pubitemid 46846981)
67. Chen, Z.; Fan, J.; Kende, A.S., Total Synthesis of (±)- Alantrypinone by Hetero Diels-Alder Reaction. J. Org. Chem., 2004, 69, 79-85. (Pubitemid 38040810)
68. Hart, D.J.; Oba, G., Synthesis and absolute configuration of (-)-serantrypinone. Tetrahedron Lett., 2007, 48, 7069-7071. (Pubitemid 47364743)
69. Liu, J.-F.; Ye, P.; Zhang, B.; Bi, G.; Sargent, K.; Yu, L.; Yohannes, D.; Baldino, C.M., Three-Component One-Pot Total Syntheses of Glyantrypine, Fumiquinazoline F, and Fiscalin B Promoted by Microwave Irradiation. J. Org. Chem., 2005, 70, 6339-6345. (Pubitemid 41076518)
70. Tseng, M.-C.; Chu, Y.-H., Zinc triflate-catalyzed synthesis of pyrazino[2,1-b]quinazoline-3,6-diones. Tetrahedron, 2008, 64, 9515-9520.
71. Watanabe, T.; Arisawa, M.; Narusuye, K.; Alam, M.S.; Yamamoto, K.; Mitomi, M.; Ozoe, Y.; Nishida, A., Alantrypinone and its derivatives and Synthesis and antagonist activity toward insect GABA receptors. Bioorg. Med. Chem., 2009, 17, 94-110.
72. Kuriyama, T.; Kakemoto, E.; Takahashi, N.; Imamura, K.-i.; Oyama, K.; Suzuki, E.; Harimaya, K.; Yaguchi, T.; Ozoe, Y., Receptor assay-guided isolation of anti-gabaergic insecticidal alkaloids from a fungal culture. J. Agric. Food Chem., 2004, 52, 3884-3887.
73. Pereira, M.D.F.; Chevrot, R.; Rosenfeld, E.; Thiery, V.; Besson, T., Synthesis and evaluation of the antimicrobial activity of novel quinazolinones. J. Enzyme Inhib. Med. Chem., 2007, 22, 577-583. (Pubitemid 47604675)
74. Sorra, K.; Pusuluri, S.; Mukkanti, K., Palladium catalyzed synthesis of quinazolino [1,4] benzodiazepine alkaloids and analogous. Tetrahedron, 2012, 68, 2001 -2006.
75. Fang, J.; Zhou, J., Efficient syntheses of 2,3-disubstituted natural quinazolinones via iridium catalysis. Org. Biomol. Chem., 2012, 10, 2389-2391.
76. Tseng, M.-C.; Lai, C.-Y.; Chu, Y.-W.; Chu, Y.-H., Tin triflate-mediated total synthesis of circumdatin F, sclerotigenin, asperlicin C, and other quinazolino[3,2-A][1,4]benzodiazepines. Chem. Commun., 2009, 445-447.
77. Kshirsagar, U.A.; Argade, N.P., Copper-catalyzed intramolecular N-Arylation of quinazolinones: facile convergent approach to (-)-circumdatins H and J. Org Lett, 2010, 12, 3716-3719.
78. Tseng, M.-C.; Yang, H.-Y.; Chu, Y.-H., Total synthesis of asperlicin C, circumdatin F, demethylbenzomalvin A, demethoxycircumdatin H, sclerotigenin, and other fused quinazolinones. Org. Biomol. Chem., 2010, 8, 419-427.
79. Liu, J.-F.; Kaselj, M.; Isome, Y.; Chapnick, J.; Zhang, B.; Bi, G.; Yohannes, D.; Yu, L.; Baldino, C.M., Microwave-Assisted Concise Total Syntheses of Quinazolinobenzodiazepine Alkaloids. J. Org. Chem., 2005, 70, 10488-10493. (Pubitemid 41759922)
80. Grieder, A.; Thomas, A.W., A Concise Building Block Approach to a Diverse Multi-Arrayed Library of the Circumdatin Family of Natural Products. Synthesis, 2003, 1707-1711. (Pubitemid 36994015)
81. Zhichkin, P.E.; Jin, X.; Zhang, H.; Peterson, L.H.; Ramirez, C.; Snyder, T.M.; Burton, H.S., A concise synthesis of enantiopure circumdatins E, H and J. Org. Biomol. Chem., 2010, 8, 1287-1289.
82. Ishikawa, K.; Hosoe, T.; Itabashi, T.; Sato, F.; Wachi, H.; Nagase, H.; Yaguchi, T.; Kawai, K.-i., Quinazolinobenzodiazepine derivatives, novobenzomalvins A-C: fibronectin expression regulators from Aspergillus novofumigatus. Sci. Pharm., 2011, 79, 937-950.
83. Örfi, L.; Kökösi, J.; György, S.; Kövesdi, I.; Mak, M.; Teplan, I.; Kéri, G., Heterocondensed quinazolinones: synthesis ans protein-Tyrosine kinase inhibitory activity of 3,4-dihydro-1H,6H-[1,4] oxazino[3,4-b]quinazolin-6-one derivatives. Bioorg. Med. Chem., 1996, 4, 547-551.
84. Alagarsamy, V.; Shankar, D.; Murugesan, S., Synthesis of 4-butyl-1-substituted-4H-[1,2,4]triazolo[4,3-A]quinazolin-5-ones as new class of H1-Antihistaminic agents. Biomed. Pharmacother., 2008, 62, 173-178. (Pubitemid 351381935)
85. Alagarsamy, V.; Meena, S.; Ramaseshu, K.V.; Solomon, V.R.; Kumar, T.D.A., 4-Cyclohexyl-1-substituted-4H-[1,2,4]triazolo[4,3-A] quinazolin-5-ones: Novel Class of H1-Antihistaminic Agents. Chem. Biol. Drug Des., 2007, 70, 158-163. (Pubitemid 47228661)
86. Angibaud, P.; Bourdrez, X.; End, D.W.; Freyne, E.; Janicot, M.; Lezouret, P.; Ligny, Y.; Mannens, G.; Damsch, S.; Mevellec, L.; Meyer, C.; Muller, P.; Pilatte, I.; Poncelet, V.; Roux, B.; Smets, G.; Van Dun, J.; Van Remoortere, P.; Venet, M.; Wouters, W., Substituted Azoloquinolines and -quinazolines as New Potent Farnesyl Protein Transferase Inhibitors. Bioorg. Med. Chem. Lett., 2003, 13, 4365-4369. (Pubitemid 37490819)
87. Kumar, K.S.; Kumar, P.M.; Rao, V.S.; Jafar, A.A.; Meda, C.L.; Kapavarapu, R.; Parsa, K.V.; Pal, M., A new cascade reaction: concurrent construction of six and five membered rings leading to novel fused quinazolinones. Org. Biomol. Chem., 2012, 10, 3098-3103.
88. Jahng, K.C.; Kim, S.; Kim, D.H.; Seo, C.S.; Son, J.-K.; Lee, S.H.; Lee, E.S.; Jahng, Y., One-Pot Synthesis of Simple Alkaloids: 2,3-Polymethylene-4(3H)- quinazolinones, Luotonin A, Tryptanthrin, and Rutaecarpine. Chem. Pharm. Bull., (Tokyo), 2008, 56, 607-609. (Pubitemid 351520155)
89. Lee, C.-S.; Liu, C.-K.; Chiang, Y.-L.; Cheng, Y.-Y., One-pot reductivecyclization as key step for the synthesis of rutaecarpine alkaloids. Tetrahedron Lett., 2008, 49, 481-484. (Pubitemid 350266768)
90. Domon, L.; Le Coeur, C.; Grelard, A.; Thiéry, V.; Besson, T., Efficient modified von Niementowski synthesis of novel derivatives of 5a,14b,15-Triazabenzo[a]indeno[1,2-c]anthracen-5-one from indolo[1,2-c] quinazoline. Tetrahedron Lett., 2001, 42, 6671-6674. (Pubitemid 32786744)
91. Laddha, S.S.; Bhatnagar, S.P., Efficient Niementowski synthesis of novel 1,3,10,12-Tetra-substituted-8H-pyrido[2',3':4,5]pyrimido[6,1-b] quinazolin-8-ones. Arkivoc, 2007, (xvi), 1-11.
92. Girniene, J.; Apremont, G.; Tatibouët, A.; Sackus, A.; Rollin, P., Small libraries of fused quinazolinone-sugars. Access to quinazolinedione nucleosides. Tetrahedron, 2004, 60, 2609-2619. (Pubitemid 38249578)
93. Bowman, W.R.; Elsegood, M.R.J.; Stein, T.; Weaver, G.W., Radical reactions with 3H -quinazolin-4-ones: synthesis of deoxyvasicinone, mackinazolinone, luotonin A, rutaecarpine and tryptanthrin. Org. Biomol. Chem., 2007, 5, 103-113. (Pubitemid 44927107)
94. Desjardins, J.; Emerson, D.L.; Colagiovanni, D.B.; Abbot, E.; Brown, E.N.; Drolet, D.W., Pharmacokinetics, Safety, and Efficacy of a Liposome Encapsulated Thymidylate Synthase Inhibitor, OSI-7904L [(S)-2-[5-[(1,2-Dihydro- 3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl] -glutaric Acid] in Mice. J. Pharm. Exp. Ther., 2004, 309, 894-902. (Pubitemid 38669676)
95. Bavetsias, V.; Marriott, J.H.; Melin, C.; Kimbell, R.; Matusiak, Z.S.; Boyle, F.T.; Jackman, A.L., Design and Synthesis of Cyclopenta[g]quinazoline- Based Antifolates as Inhibitors of Thymidylate Synthase and Potential Antitumor Agents. J. Med. Chem., 2000, 43, 1910-1926. (Pubitemid 30340931)
96. Jackman, A.L.; Theti, D.S.; Gibbs, D.D., Antifolates targeted specifically to the folate receptor. Adv. Drug Deliv. Rev., 2004, 56, 1111-1125. (Pubitemid 38496511)
97. Pillai, R.G.; Forster, M.; Perumal, M.; Mitchell, F.; Leyton, J.; Aibgirhio, F.I.; Golovko, O.; Jackman, A.L.; Oboagye, E.O., Imaging Pharmacodynamics of the -Folate Receptor-Targeted Thymidylate Synthase Inhibitor BGC 945. cancer Res., 2008, 68, 3827-3834.
98. Theti, D.S.; Bavetsias, V.; Skelton, L.A.; Titley, J.; Gibbs, D.; Jansen, G.; Jackman, A.L., Selective Delivery of CB300638, a Cyclopenta[g]quinazoline- based Thymidylate Synthase Inhibitor into Human Tumor Cell Lines Overexpressing the alpha-Isoform of the Folate Receptor. Cancer Res., 2003, 63, 3612-3618. (Pubitemid 36793043)
99. Henderson, E.A.; Bavetsias, V.; Theti, D.S.; Wilson, S.C.; Clauss, R.; Jackman, A.L., Targeting the -folate receptor with cyclopenta[g]quinazoline- based inhibitors of thymidylate synthase. Bioorg. Med. Chem., 2006, 14, 5020-5042. (Pubitemid 43767126)
100. Gibbs, D.D.; Theti, D.S.; Wood, N.; Green, M.; Raynaud, F.; Valenti, M.; Forster, M.D.; Mitchell, F.; Bavetsias, V.; Henderson, E.; Jackman, A.L., BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to -Folate Receptor-Overexpressing Tumors. Cancer Res., 2005, 65, 11721-11728. (Pubitemid 41821733)
101. Bavetsias, V.; Clauss, R.; Henderson, E.A., Antifolate chemistry: synthesis of 4-{N-[(6RS)-2-methyl-4-oxo-3,4,7,8-Tetrahydro-6Hcyclopenta[ g]quinazolin-6-yl]-N-(prop-2-ynyl)amino}benzoic acid via a (propargyl)Co2(CO)6 + complex Org. Biomol. Chem., 2003, 1, 1943-1946.
102. Lazzaro, J.T.; Paternain, A.V.; Lerma, J.; Chenard, B.L.; Ewing, F.E.; Huang, J.; Welch, W.M.; Ganong, A.H.; Menniti, F.S., Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist. Neuropharm., 2002, 42, 145-153.
103. Zappalá, M.; Grasso, S.; Micale, N.; Zuccalá, G.; Menniti, F.S.; De Sarro, G.; De Micheli, C., 1-Aryl-6,7-methylenedioxy-3H-quinazolin-4- ones as Anticonvulsant Agents. Bioorg. Med. Chem. Lett., 2003, 13, 4427-4430. (Pubitemid 37490831)
104. Micale, N.; Postorino, G.; Grasso, S.; Zappalá, M.; Zuccalá, G.; Ferreri, G.; De Sarro, G., Synthesis of Novel 3-(Alkylcarbamoyl)-2-Aryl-1,2-dihydro-6,7-(methylenedioxy)-3H-quinazolin-4-ones as Anticonvulsant Agents. Chem. Biodiversity, 2006, 3, 304-311.
105. Jiang, S.; Zeng, Q.; Gettayacamin, M.; Tungtaeng, A.; Wannaying, S.; Lim, A.; Hansurkjariya, P.; Okunji, C.O.; Zhu, S.; Fang, D., Antimalarial Activities and Therapeutic Properties of Febrifugine Analogs. Antimicrob. Agents Chemother., 2005, 49, 1169-1176. (Pubitemid 40327741)
106. Lee, J.Y.; Park, Y.K.; Seo, S.H.; So, I.-K.; Chung, H.-K.; Yang, B.-S.; Lee, S.J.; Park, H.; Lee, Y.S., 1,4-Dioxane-fused 4-Anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase. Arch. Pharm. Chem. Life Sci., 2001, 334, 357-360. (Pubitemid 34027246)
107. Lee, J.Y.; Park, Y.K.; Seo, S.H.; Yang, B.-S.; Park, H.; Lee, Y.S., 7-Substituted-[1,4]dioxano[2,3-g]quinazolines as Inhibitors of Epidermal Growth Factor Receptor Kinase. Arch. Pharm. Chem. Life Sci., 2002, 10, 487-494. (Pubitemid 36125517)
108. Lee, Y.S.; Seo, S.H.; Yang, B.-S.; Lee, J.Y., Synthesis and Biological Evaluation of Bis(methoxymethyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR Tyrosine Kinase Inhibitors. Arch. Pharm. Chem. Life Sci., 2005, 338, 502-505. (Pubitemid 41564262)
109. Ha, J.D.; Kang, S.K.; Kim, K.-D.; Choi, J.-K.; Kong, J.Y.; Ahn, C.H., Design and Synthesis of Novel Epidermal Growth Factor Receptor Kinase Inhibitors. Bull. Korean Chem. Soc., 2005, 26, 959-965. (Pubitemid 41032419)
110. Chilin, A.; Conconi, M.T.; Marzaro, G.; Guiotto, A.; Urbani, L.; Tonus, F.; Parnigotto, P., Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold. J. Med. Chem., 2010, 53, 1862-1866.
111. Godde, F.; Toulme, J.J.; Moreau, S., 4-Amino-1H-benzo[g]quinazolin-2-one: A fluorescent analog of cytosine to probe protonation sites in triplex forming oligonucleotides. Nucleic Acids Res., 2000, 28, 2977-2985. (Pubitemid 30601341)
112. Arzumanov, A.; Godde, F.; Moreau, S.; Toulme, J.J.; Weeds, A.; Gait, M.J., Use of the fluorescent nucleoside analogue benzo[g]quinazoline 2'-Omethyl-D-ribofuranoside to monitor the binding of the HIV-1 Tat protein or of antisense oligonucleotides to the TAR-RNA stem-loop. Helv. Chim. Acta, 2000, 83, 1424-1436. (Pubitemid 30489521)
113. Patel, B.B.; Patel, R.G.; Patel, J.M., Synthesis and studies of the biological activity of novel pyrimido fused acridine derivatives. J. Serb. Chem. Soc., 2006, 71, 1015-1023.
114. Skibo, E.B.; Huang, X.; Martinez, R.; Lemus, R.H.; Craigo, W.A.; Dorr, R.T., Pyrimidoquinazoline-Based Antitumor Agents. Design of Topoisomerase II to DNA Cross-linkers with Activity against Protein Kinases. J. Med. Chem., 2002, 45, 5543-5555. (Pubitemid 35424972)
115. Krueger, A.T.; Lu, H.; Lee, A.H.F.; Kool, E.C., Synthesis and Properties of Size-Expanded DNAs: Toward Designed, Functional Genetic Systems. Acc. Chem. Res., 2007, 40, 141-150.
116. Liu, H.; Gao, J.; Kool, E.T., Size-expanded analogues of dG and dC: synthesis and pairing properties in DNA. J. Org. Chem., 2005, 70, 639-647. (Pubitemid 40129428)
117. Lee, A.H.F.; Kool, E.C., Exploring the Limits of DNA Size: Naphtho-Homologated DNA Bases and Pairs. J. Am. Chem. Soc., 2006, 128, 9219-9230. (Pubitemid 44079004)
118. Hörtner, S.; Ritschel, T.; Stengl, B.; Kramer, C.; Schweizer, W.B.; Wagner, B.; Kansy, M.; Klebe, G.; Diederich, F., Potent Inhibitors of tRNA-Guanine Transglycosylase, an Enzyme Linked to the Pathogenicity of the Shigella Bacterium: Charge-Assisted Hydrogen Bonding. Angew. Chem. Int. Ed., 2007, 46, 8266-8269. (Pubitemid 350096614)
119. Meyer, E.A.; Donati, N.; Guillot, M.; Schweizer, W.B.; Diederich, F., Synthesis, Biological Evaluation, and Crystallographic Studies of Extended Guanine-Based (lin-Benzoguanine) Inhibitors for tRNA-Guanine Transglycosylase (TGT). Helv. Chim. Acta, 2006, 89, 573-597.
120. Stengl, B.; Meyer, E.A.; Heine, A.; Brenk, R.; Diederich, F.; Klebe, G., Crystal Structures of tRNA-guanine Transglycosylase (TGT) in Complex with Novel and Potent Inhibitors Unravel Pronounced Induced-fit Adaptations and Suggest Dimer Formation Upon Substrate Binding. J. Mol. Biol., 2007, 370, 492-511. (Pubitemid 46898428)
121. Stengl, B.; Reuter, K.; Klebe, G., Mechanism and Substrate Specificity of tRNA-Guanine Transglycosylases (TGTs): tRNA Modifying Enzymes from the Three Different Kingdoms of Life Share a Common Catalytic Mechanism. ChemBioChem, 2005, 6, 1926-1939. (Pubitemid 41598161)
122. Testard, A.; Logé, C.; Léger, B.; Robert, J.-M.; Lozach, O.; Blairvacq, M.; Meijer, L.; Thiéry, V.; Besson, T., Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3. Bioorg. Med. Chem. Lett., 2006, 16, 3419-3423. (Pubitemid 43841755)
123. Testard, A.; Picot, L.; Lozach, O.; Blairvacq, M.; Meijer, L.; Murillo, L.; Piot, J.-M.; Thiéry, V.; Besson, T., Synthesis and evaluation of the antiproliferative activity of novel thiazoloquinazolinone kinases inhibitors. J. Enz. Inhib. Med. Chem., 2005, 20, 557-568. (Pubitemid 43994753)
124. Tarasiuk, J.; Majewska, E.; Seksek, O.; Rogacka, D.; Antonini, I.; Garnier-Suillerot, A.; Borowski, E., The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines Implications for overcoming multidrug resistance towards leukaemia K562/DOX cells. Biochem. Pharmacol., 2004, 68, 1815-1823. (Pubitemid 39278504)
125. Antonini, I.; Polucci, P.; Magnano, A.; Sparapani, S.; Martelli, A., Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de] acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents. J. Med. Chem., 2004, 47, 5244-5250. (Pubitemid 39314922)
126. Antonini, I.; Santoni, G.; Lucciarini, R.; Amantini, C.; Sparapani, S.; Magnano, A., Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs. J. Med. Chem., 2006, 49, 7198-7207. (Pubitemid 44886005)
127. Kamata, J.; Okada, T.; Kotake, Y.; K., N.; Uenaka, T.; Yamaguchi, A.; Tsukahara, K.; Nagasu, T.; Koyanagi, N.; Kitoh, K.; Yoshimatsu, K.; Yoshino, H.; Sugumi, H., Synthesis and evaluation of novel pyrimidoacridone, -phenoxazine, and -carbazole as topoisomerase II inhibitors. Chem. Pharm. Bull., (Tokyo), 2004, 52, 1071-1081. (Pubitemid 41679545)
128. Nakamura, K.; Uenaka, T.; Nagasu, T.; Sugumi, H.; Yamaguchi, A.; Kotake, Y.; Okada, T.; Kamata, J.; Niijima, J.; Taniguchi, T.; Koyanagi, N.; Yoshino, H.; Kitoh, K.; Yoshimatsu, K., A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo. Cancer Sci., 2003, 94, 119-124. (Pubitemid 36575869)
129. Nakamura, K.; Taniguchi, T.; Funahashi, Y.; Yoshimatsu, K., Effects of ER-37328 on primary tumor, liver metastasis, and life span in a murine colon 38 orthotopic transplantation model. Mol. Cancer Ther., 2003, 2, 59-64.
130. Chandregowda, V.; Rao, G.V.; Reddy, G.C., One-pot conversion of 2 nitrobenzonitriles to quinazolin-4(3H)-ones and synthesis of gefitinib and erlotinib hydrochloride. Heterocycles, 2007, 71, 39-48.
131. Guillonneau, C.; Nault, A.; Raimbaud, E.; Léonce, S.; Kraus-Berthier, L.; Pierré, A.; Goldstein, S., Cytotoxic and antitumoral properties in a series of new, ring D modified, olivacine analogues. Bioorg. Med. Chem., 2005, 13, 175-184. (Pubitemid 39575702)
132. Zeghida, W.; Debray, J.; Chierici, S.; Dumy, P.; Demeunynck, M., Concise synthesis of 2-Amino-4(3H)quinazolinones from simple (hetero)aromatic amine. J. Org. Chem., 2008, 73, 2473-2475. (Pubitemid 351497789)
133. Debray, J.; Zeghida, W.; Baldeyrou, B.; Mahieu, C.; Lansiaux, A.; Demeunynck, M., Montmorillonite K-10 catalyzed cyclization of Nethoxycarbonyl-N,-Arylguanidines: Access to pyrimido[4,5-c]carbazole and pyrimido[5,4-b]indole derivatives. Bioorg. Med. Chem. Lett., 2010, 20, 4244-4247.
134. Debray, J.; Bonte, S.; Lozach, O.; Meijer, L.; Demeunynck, M., Catalyst-free synthesis of quinazolin-4-ones from (hetero)aryl-guanidines: Application to the synthesis of pyrazolo[4,3-f]quinazolin-9-ones, a new family of DYRK1A inhibitors. Mol. Diversity, 2012, 16, 659-667.
135. Debray, J.; Zeghida, W.; Jourdan, M.; Monchaud, D.; Dheu-Andries, M.-L.; Teulade-Fichou, M.P.; Demeunynck, M., Synthesis and evaluation of fused bispyrimidoacridines as novel pentacyclic analogues of quadruplex-binder BRACO-19. Org. Biomol. Chem., 2009, 7, 5219-5228.
136. Okada, E.; Tsukushi, N., A facile and convenient synthetic method for fluorine-containing 1,2-dihydropyrido[3,2-h]quinazolines and pyrido[3,2-h]quinazolines. Heterocycles, 1999, 51, 2471-2478.
137. Guan, J.; Zhang, Q.; O'Neil, M.; Obaldia III, N.; Ager, A.; Gerena, L.; Lin, A.J., Antimalarial Activities of New Pyrrolo[3,2-f]Quinazoline-1,3-Diamine Derivatives. Antimicrob. Agents Chemother., 2005, 49, 4928-4933. (Pubitemid 41778902)
138. Alexandre, F.-R.; Berecibar, A.; Wrigglesworth, R.; Besson, T., Efficient synthesis of thiazoloquinazolinone derivatives. Tetrahedron Lett., 2003, 44, 4455-4458. (Pubitemid 36588605)
139. Bhatti, H.S.; Seshadri, S., Chromophoric potential of the 4(3H)-quinazolinones: A review. Color. Technol., 2004, 120, 101-107. (Pubitemid 38865639)